Abstract
A series of ten new 1-(aryl)-2-((3-phenyl-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazol-6-yl)thio)ethan-1-ones (4a-j) was synthesized by reacting 3-phenyl-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole-6-thiol (2) with substituted phenacyl bromides (3a-j) in the presence of N,N-diisopropylethylamine. These derivatives were comprehensively evaluated for their antimycobacterial, antibacterial, and antifungal activities. Among these, compound 4f demonstrated notable efficacy against mycobacterial, bacterial, and fungal strains, exhibiting performance comparable to standard drugs. Further, highly active compounds underwent detailed scrutiny of their binding interactions within the active site using the co-crystal structures of Mycobacterium tuberculosis (Protein Data Bank [PDB] ID 2x22) and glucosamine-6-phosphate synthase (PDB ID 2VF5), followed by rigorous molecular dynamics (MD) simulations. MD simulations were conducted for 300 ns to study the stability and behavior of both the ligand-protein complexes (2x22-4f and 2vf5-4f). The root mean square deviation values for complex 4f with proteins 2x22 and 2vf5 were found to be 3.2x3.5 Å and 2.6x2.8 Å, respectively, indicating the stability of the complexes.. KEYWORDS :Antibacterial, Antifungal, Antimycobacterial, Molecular Docking, Molecular Dynamics, Root mean square deviation.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.